Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare.

Bynum J, Song Y, Fisher E.

J Am Geriatr Soc. 2010 Apr;58(4):674-80. doi: 10.1111/j.1532-5415.2010.02761.x. Epub 2010 Mar 22.

2.

Variation among primary care physicians in prostate-specific antigen screening of older men.

Jaramillo E, Tan A, Yang L, Kuo YF, Goodwin JS.

JAMA. 2013 Oct 16;310(15):1622-4. doi: 10.1001/jama.2013.277514. No abstract available.

4.

Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.

So C, Kirby KA, Mehta K, Hoffman RM, Powell AA, Freedland SJ, Sirovich B, Yano EM, Walter LC.

J Gen Intern Med. 2012 Jun;27(6):653-60. doi: 10.1007/s11606-011-1945-9. Epub 2011 Dec 17.

5.

Prostate-specific antigen testing among the elderly in community-based family medicine practices.

Hudson SV, Ohman-Strickland P, Ferrante JM, Lu-Yao G, Orzano AJ, Crabtree BF.

J Am Board Fam Med. 2009 May-Jun;22(3):257-65. doi: 10.3122/jabfm.2009.03.080136.

6.

National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.

Drazer MW, Huo D, Eggener SE.

J Clin Oncol. 2015 Aug 1;33(22):2416-23. doi: 10.1200/JCO.2015.61.6532. Epub 2015 Jun 8.

PMID:
26056181
7.

A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.

Kim SP, Karnes RJ, Nguyen PL, Ziegenfuss JY, Thompson RH, Han LC, Shah ND, Smaldone MC, Gross CP, Frank I, Weight CJ, Beebe TJ, Tilburt JC.

BJU Int. 2014 May;113(5b):E106-11. doi: 10.1111/bju.12422. Epub 2014 Jan 17.

8.

National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.

Drazer MW, Prasad SM, Huo D, Schonberg MA, Dale W, Szmulewitz RZ, Eggener SE.

Cancer. 2014 May 15;120(10):1491-8. doi: 10.1002/cncr.28600. Epub 2014 Feb 12.

9.

Primary care providers' perspectives on discontinuing prostate cancer screening.

Pollack CE, Platz EA, Bhavsar NA, Noronha G, Green GE, Chen S, Carter HB.

Cancer. 2012 Nov 15;118(22):5518-24. doi: 10.1002/cncr.27577. Epub 2012 Apr 19.

10.

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.

Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ.

Am J Med. 1998 Jun;104(6):526-32.

PMID:
9674714
11.

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

Sirovich BE, Schwartz LM, Woloshin S.

JAMA. 2003 Mar 19;289(11):1414-20.

PMID:
12636464
12.

Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices.

Ruffin MT, Gorenflo DW, Woodman B.

J Am Board Fam Pract. 2000 Jan-Feb;13(1):1-10. Review.

PMID:
10682879
13.

Prostate cancer screening trends in a large, integrated health care system.

Wallner L, Frencher S, Hsu JW, Loo R, Huang J, Nichol M, Jacobsen S.

Perm J. 2012 Summer;16(3):4-9.

14.

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

Etzioni R, Berry KM, Legler JM, Shaw P.

Urology. 2002 Feb;59(2):251-5.

PMID:
11834397
15.

PSA screening among elderly men with limited life expectancies.

Walter LC, Bertenthal D, Lindquist K, Konety BR.

JAMA. 2006 Nov 15;296(19):2336-42.

PMID:
17105796
16.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
17.

African american primary care physicians' prostate cancer screening practices.

Ross LE, Hall IJ.

J Prim Care Community Health. 2014 Jan 1;5(1):36-43. doi: 10.1177/2150131913507454. Epub 2013 Oct 17.

18.

Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey.

Guerra CE, Gimotty PA, Shea JA, Pagán JA, Schwartz JS, Armstrong K.

Med Decis Making. 2008 Sep-Oct;28(5):681-9. doi: 10.1177/0272989X08315243. Epub 2008 Jun 12.

19.

Prostate-specific antigen testing rates and referral patterns from general practice data in England.

Moss S, Melia J, Sutton J, Mathews C, Kirby M.

Int J Clin Pract. 2016 Apr;70(4):312-8. doi: 10.1111/ijcp.12784. Epub 2016 Mar 14.

PMID:
26987766
20.

The role of increasing detection in the rising incidence of prostate cancer.

Potosky AL, Miller BA, Albertsen PC, Kramer BS.

JAMA. 1995 Feb 15;273(7):548-52.

PMID:
7530782

Supplemental Content

Support Center